AMIKACIN PHARMACOKINETICS DURING CONTINUOUS VENOVENOUS HEMOFILTRATION - REPLY

被引：0
|
作者：
CHELLURI, L
PTACHCINSKI, R
机构：
来源：
CRITICAL CARE MEDICINE | 1991年 / 19卷 / 04期
关键词：
D O I：
10.1097/00003246-199104000-00030
中图分类号：
R4 [临床医学];
学科分类号：
1002 ; 100602 ;
摘要：
引用
下载
收藏
页码：589 / 589
页数：1
相关论文
共 50 条
  • [21] Evaluation of digoxin pharmacokinetics in a patient undergoing continuous venovenous hemofiltration
    Benken, Scott T.
    Lizza, Bryan D.
    PHARMACOTHERAPY, 2012, 32 (10): : E237 - E237
  • [22] VANCOMYCIN PHARMACOKINETICS IN HIGH-FLOW CONTINUOUS VENOVENOUS HEMOFILTRATION
    Paciullo, Christopher
    Davis, George
    Harned, Kevin
    Winstead, Shane
    CRITICAL CARE MEDICINE, 2009, 37 (12) : A419 - A419
  • [23] Single-Dose Pharmacokinetics of Cidofovir in Continuous Venovenous Hemofiltration
    Vossen, Matthias G.
    Gattringer, Klaus-Bernhard
    Jaeger, Walter
    Kraff, Stefanie
    Thalhammer, Florian
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2014, 58 (04) : 1952 - 1955
  • [24] Vancomycin removal and pharmacokinetics during accelerated venovenous hemofiltration
    Lopez, Natasha D.
    Griggs, Michael
    Sin, Jonathan H.
    Roberts, Russel J.
    Allegretti, Andrew S.
    PHARMACOTHERAPY, 2024, 44 (01): : 69 - 76
  • [25] Single-dose pharmacokinetics of ofloxacin during continuous venovenous hemofiltration in critical care patients
    Fuhrmann, V
    Schenk, P
    Mittermayer, C
    El Menyawi, I
    Ratheiser, K
    Thalhammer, F
    AMERICAN JOURNAL OF KIDNEY DISEASES, 2003, 42 (02) : 310 - 314
  • [26] Once-Daily Amikacin Dosing in Burn Patients Treated with Continuous Venovenous Hemofiltration
    Akers, Kevin S.
    Cota, Jason M.
    Frei, Christopher R.
    Chung, Kevin K.
    Mende, Katrin
    Murray, Clinton K.
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2011, 55 (10) : 4639 - 4642
  • [27] Pharmacokinetics of cefpirome during continuous venovenous hemofiltration:: Rationale for an 8-hour dosing interval
    Banyai, M
    Thalhammer, F
    El Menyawi, I
    Heinz, G
    Traunmüller, F
    Siostrzonek, P
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2000, 67 (04) : 368 - 372
  • [28] Pharmacokinetics and drug dosing adjustments during continuous venovenous hemofiltration or hemodiafiltration in critically ill patients
    Bugge, JF
    ACTA ANAESTHESIOLOGICA SCANDINAVICA, 2001, 45 (08) : 929 - 934
  • [29] Lacosamide Pharmacokinetics in a Critically Ill Patient Receiving Continuous Venovenous Hemofiltration
    Franquiz, Miguel J.
    Kalaria, Shamir N.
    Armahizer, Michael J.
    Gopalakrishnan, Mathangi
    McCarthy, Paul J.
    Badjatia, Neeraj
    PHARMACOTHERAPY, 2018, 38 (02): : E17 - E21
  • [30] Pharmacokinetics of linezolid in critically ill patients undergoing continuous venovenous hemofiltration
    B Meyer
    G Kornek
    M Nikfardjam
    G Delle Karth
    G Heinz
    G Locker
    W Jaeger
    F Thalhammer
    Critical Care, 8 (Suppl 1):
12345